Stock PSTX POSEIDA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Poseida Therapeutics, Inc.

Equities

PSTX

US73730P1084

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
2.645 USD -2.40% Intraday chart for Poseida Therapeutics, Inc. -7.84% -21.28%
05-02 Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos MT
05-01 Malin Corp investee signs agreement with Astellas Pharma AN

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Poseida Therapeutics Appoints Syed Rizvi as Chief Medical Officer
MT
Poseida Therapeutics, Inc Appoints Syed Rizvi as Chief Medical Officer Effective April 1, 2024
CI
Poseida Therapeutics, Inc. Announces Executive Changes
CI
Poseida Therapeutics, Inc. Announces Board Changes
CI
Poseida Therapeutics, Inc. Announces Chief Executive Officer Changes
CI
Poseida Therapeutics Names Kristin Yarema as CEO, Mark Gergen as Executive Chairman
MT
Poseida Therapeutics, Inc. Appoints Kristin Yarema as President, Cell Therapy
CI
Poseida Therapeutics, Inc. Appoints Five New Members to Its Gene Therapy Scientific Advisory Board
CI
Poseida Therapeutics Executive Chairman Resigns; Shares Fall After-Hours
MT
Poseida Therapeutics, Inc. Announces Resignation of Eric Ostertag as Executive Chairman and Retirement from the Board of Directors, Effective February 3, 2023
CI
Poseida Therapeutics, Inc. Announces Appointment of George M. Church as Chair of Gene Therapy Scientific Advisory Board
CI
Poseida Therapeutics Appoints Charles M. Baum to Board of Directors
CI
Matthew Spear Informs Poseida Therapeutics, Inc. of His Intent to Resign from Chief Medical Officer Position, Effective April 22, 2022
CI
Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy
CI
Poseida Therapeutics President Mark Gergen Named CEO, Wll Succeed Eric Ostertag in February
MT
Poseida Therapeutics, Inc. Announces Executive Changes
CI
Poseida Therapeutics Announces Mark Gergen as Chief Executive Officer, Effective February 1, 2022
CI
Poseida Therapeutics : Promotes Johanna Mylet to Finance Chief
MT
Poseida Therapeutics Announces Leadership Appointments
CI
Poseida Therapeutics Announces Leadership Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PSTX Stock
  4. News Poseida Therapeutics, Inc.
  5. Insiders